Loading clinical trials...
Loading clinical trials...
A Multi-Center, Randomized, Open-Label, Parallel-Group Study With LJPC-401 for the Treatment of Myocardial Iron Overload in Patients With Transfusion-Dependent Beta Thalassemia
Conditions
Interventions
LJPC-401
LJPC-401
Locations
22
United States
Investigative Site
Oakland, California, United States
Investigative Site
New York, New York, United States
Investigative Site
Camperdown, New South Wales, Australia
Investigative Site
Liverpool, New South Wales, Australia
Investigative Site
Goudi, Attica, Greece
Investigative Site
Thessaloniki, Macedonia, Greece
Start Date
November 30, 2017
Primary Completion Date
December 3, 2019
Completion Date
January 14, 2020
Last Updated
July 29, 2021
NCT06647979
NCT06308159
NCT03653338
NCT06772766
NCT06606886
NCT06734520
Lead Sponsor
La Jolla Pharmaceutical Company
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions